Skip to content

Investors

Conference Call on Q2 2024 financial results

The Conference Call on Q2 2024 financial results took place on July 30, 2024.
Learn more

Q2 2024 Investor Presentation

and upcoming conferences & roadshow dates at a glance.
Learn more

HDF Expert Call

September 16, 2024 - Insights into high-volume hemodiafiltration (HDF) therapy from a medical perspective.
Learn more

Sustainability

Managing sustainability successfully means creating lasting value – economically, ecologically and socially.
Learn more

You are interested in our news?

We would be happy to provide you with our latest press releases and short news by e-mail.
Learn more

Contacts

The Investor Relations Team is pleased to answer your questions regarding our share, financial performance or other capital market related questions.
Learn more
| Reporting

Q3 2024 Quiet Period

Save the date
| Reporting

Report on 3rd quarter 2024: Earnings Release and Conference Call

Save the date
| Reporting

Quarterly financial report within the second half year (Q3)

Save the date
| Reporting

Q4/FY 2024 Quiet Period

Save the date
| Conference

Berenberg & Goldman Sachs German Corporate Conference

Munich
Save the date
| Conference

Bernstein 20th Pan European Annual Strategic Decisions Conference

London
Save the date
| Roadshow

Q3 2024 CEO Roadshow

London
Save the date
| Conference

UBS Flagship European Conference

London
Save the date

You are interested in our news?

Order our news

Would you like to be included on our distribution list for our news? We would be happy to provide you with our latest press releases and short news by e-mail. This service is free of charge and may be cancelled at any time.

You can cancel this free service at any time by sending an e-mail to
ir(at)freseniusmedicalcare.com, or by calling +49 (0) 6172 - 609 2525.

The information you provide will only be used to answer your query. For more information on how we process your Personal Data please read our 
privacy policy.

newsletter registration
captcha